Brisdelle?

Brisdelle® (bremelanotide) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone‑related hypoactive sexual desire disorder (HSDD) in pre‑menopausal women. In simpler terms, it is used to help women who have a low desire for sexual activity that interferes with their quality of life.

---

How it Works

• Mechanism: Bremelanotide is a synthetic analog of the naturally occurring hormone melanocortin. It activates melanocortin‑4 receptors in the brain, which can increase sexual desire and motivation.
• Non‑hormonal: It does not contain estrogen, progesterone, or testosterone, so it can be used safely in women who cannot take hormonal therapies.

---

How to Use

Step	Action	Tips
1	Self‑inject 0.75 mg intramuscularly (usually in the thigh) 45 minutes before anticipated sexual activity.	Use a new needle each time.
2	Limit to 3 injections per week (not more than once per 8 hours).	If you need more frequent help, talk to your provider about a different therapy.
3	Keep refrigerated (2–8 °C) until you’re ready to use.	Do not freeze or expose to high heat.
4	Use the injection kit properly. Follow the instructions for drawing up the medication, injecting, and disposing of the used syringe.	Seek a demonstration if you’re uncertain.

---

What to Expect (Typical Side Effects)

Common	Rare	Serious
Nausea, vomiting	Hypertension spikes	Priapism (in men, but not applicable to women)
Injection‑site pain, redness	Hypotension	Severe allergic reaction
Headache	Liver enzyme elevations
Flushing

Most side‑effects are mild to moderate and tend to improve with repeated use or by adjusting the timing of the injection.

---

Contraindications & Precautions

Condition	Why It Matters
Active hypertension or uncontrolled blood pressure	Bremelanotide can raise blood pressure temporarily.
Severe liver impairment	Metabolized by the liver; may accumulate.
Pregnancy or breastfeeding	Limited data; generally avoided.
Known hypersensitivity to bremelanotide or any component of the injection.

Drug Interactions:

• CYP enzymes: Bremelanotide is metabolized primarily by CYP2D6 and CYP1A2. Drugs that inhibit or induce these enzymes could alter its levels.
• Blood‑pressure‑lowering drugs: May enhance blood‑pressure‑lowering effects, leading to hypotension.
• Other CNS‑acting drugs (e.g., opioids): Additive effects on sexual function or mood may occur.

Always discuss your full medication list (including OTC supplements) with your prescriber.

---

Who It’s For & Who It’s Not For

Group	Recommendation
Premenopausal women with clinically diagnosed HSDD	Appropriate
Men	Not recommended (risk of priapism)
Postmenopausal women	Not FDA‑approved, but sometimes used off‑label; discuss risks.
Pregnant or nursing women	Generally avoided

---

Cost & Insurance

• Average cost (out‑of‑pocket): ~$1,200–$1,400 for a 4‑injection pack (price varies by region).
• Many insurers cover Brisdelle after prior authorization; check your plan’s formulary.

---

Quick FAQ

Question	Answer
Can I take it daily?	No—use only up to three times per week, 45 min before sexual activity.
What if I miss a dose?	Just use it for your next planned activity; no “catch‑up” dose.
Can I use it with alcohol?	Alcohol may worsen nausea or hypotension—use cautiously.
Is it a hormone replacement therapy?	No, it’s a non‑hormonal melanocortin agonist.
Do I need a prescription?	Yes, Brisdelle is prescription‑only.

---

Bottom Line

Brisdelle is a novel, non‑hormonal option for pre‑menopausal women struggling with low sexual desire. Its effectiveness is linked to timely injection before sexual activity, and while most side‑effects are mild, monitoring blood pressure and liver function is important. Discuss your medical history, current meds, and lifestyle with a qualified provider to determine if Brisdelle is a good fit for you.